It's amazing you had NO link to your post. The only people that applies to are people who've received monoclonal antibodies.....
The most recent COVID-19 treatments given FDA emergency use authorization are different from the rest. Rather than being given to very sick patients in the hospital, they’re being given by IV infusion to prevent people from needing to be hospitalized in the first place.
Monoclonal antibodies use lab-made proteins that mimic antibodies to reduce the amount of coronavirus in a person’s body – hopefully before it gets to a level that could cause severe symptoms and land them in the hospital.
Monoclonal antibodies are approved for patients who have COVID-19 and are at a greater risk for developing complications. This includes people over the age of 65 and people with certain preexisting medical conditions such as diabetes, chronic kidney disease or obesity.
“
In studies, it was found that, with the early use of this medication, quite a few patients were able to stay out of trouble,” Dr. Venkateshaiah says. “The risk of hospitalization was lower with the medicine versus without it.”
As with the other medicines, its safety and effectiveness will continue to be studied.